IP Verse

Sarepta Therapeutics, Inc. et al. v. Genzyme Corporation et al. - IPR2026-00150

Explore the PTAB proceeding IPR2026-00150 filed by Sarepta Therapeutics, Inc. et al. against Genzyme Corporation et al. on Nov 25, 2025. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2026-00150
Filing Date
Nov 25, 2025
Petitioner
Sarepta Therapeutics, Inc. et al.
Respondent
Genzyme Corporation et al.
Status
Trial Instituted
Respondent Application Number
18513970
Respondent Tech Center
1600
Respondent Patent Number
12031894
Institution Decision Date
May 6, 2026

Decision Documents New

Decision documents related to this case provide insights into the outcomes of proceedings. These documents are crucial for understanding the legal determinations and implications for the parties involved.

Document NameFiling DateCategoryFiling Party

Institution Decision: Grant

May 6, 2026PAPERBOARD

Director Discretionary Decision: Refer

Mar 23, 2026PAPERBOARD

Counsels Involved New

Details of counsels involved in proceeding number IPR2026-00150.

TypeName
Petitioner CounselWilson, Robertet al
Respondent CounselAntons, Amandaet al

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Institution Decision: Grant

May 6, 2026PAPERBOARD

Director Discretionary Decision: Refer

Mar 23, 2026PAPERBOARD

Response to Patent Owner's Discretionary Denial Brief

Mar 4, 2026PAPERPETITIONER

Ex. 1042

Mar 4, 2026EXHIBITPETITIONER

Ex. 1043

Mar 4, 2026EXHIBITPETITIONER

Ex. 1044

Mar 4, 2026EXHIBITPETITIONER

Ex. 1045

Mar 4, 2026EXHIBITPETITIONER

Ex. 1046

Mar 4, 2026EXHIBITPETITIONER

Ex. 1047

Mar 4, 2026EXHIBITPETITIONER

Ex. 1048

Mar 4, 2026EXHIBITPETITIONER

Ex. 1049

Mar 4, 2026EXHIBITPETITIONER

Ex. 1050

Mar 4, 2026EXHIBITPETITIONER

Patent Owner's Preliminary Response

Mar 4, 2026PAPERPATENT OWNER

Q. Xie et al., The Atomic Structure of Adeno-Associated Virus (AAV-2), a Vector for Human Gene Therapy

Mar 4, 2026EXHIBITPATENT OWNER

T. Matsushita et al., Adeno-Associated Virus Vectors Can Be Efficiently Produced Without Helper Virus

Mar 4, 2026EXHIBITPATENT OWNER

J.F. Wright, Product-Related Impurities in Clinical-Grade Recombinant AAV Vectors: Characterization and Risk Assessment

Mar 4, 2026EXHIBITPATENT OWNER

D. Curran-Everett, Explorations in Statistics: Hypothesis Tests and P-values

Mar 4, 2026EXHIBITPATENT OWNER

Oliver, Christopher, Diffusion Coefficient and Molecular Weight of Type 5 Adenovirus

Mar 4, 2026EXHIBITPATENT OWNER

Tanford, Charles, Physical Chemistry of Macromolecules (1961)

Mar 4, 2026EXHIBITPATENT OWNER

Declaration of Karen G. Fleming, Ph.D.

Mar 4, 2026EXHIBITPATENT OWNER

Curriculum Vitae of Declaration of Karen G. Fleming, Ph.D.

Mar 4, 2026EXHIBITPATENT OWNER

Patent Owner's Request for Discretionary Denial

Feb 4, 2026PAPERPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 78

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 59

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 68

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 28

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 35

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 37

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 45

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 67

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 83

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 87

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 91

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 92

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 99

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 102

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 110

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 76

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) - Defendant’s Supplemental Initial Invalidity Contentions

Feb 4, 2026EXHIBITPATENT OWNER

Burnham et al., Analytical Ultracentrifugation as an Approach to Characterize Recombinant AAV Vectors

Feb 4, 2026EXHIBITPATENT OWNER

F. Collaud et al., Preclinical Development of an AAV8-hUGT1A1Vector for the Treatment of Crigler-Najjar Syndrome

Feb 4, 2026EXHIBITPATENT OWNER

E. Spies, Assessing the Quality of Adeno-Associated Virus GeneTherapy Vectors by Sedimentation Velocity Analysis

Feb 4, 2026EXHIBITPATENT OWNER

Novartis Gene Therapies, Inc. v. Genzyme Corp., IPR2023-01044,Paper 12

Feb 4, 2026EXHIBITPATENT OWNER

US 2017/0362608 to McLaughlin et al.

Feb 4, 2026EXHIBITPATENT OWNER

Novartis Gene Therapies, Inc. v. Genzyme Corp., IPR2023-01044,Paper 1

Feb 4, 2026EXHIBITPATENT OWNER

Petitioner's Sotera Stipulation

Dec 30, 2025PAPERPETITIONER

Patent Owner's Updated Mandatory Notices

Dec 24, 2025PAPERPATENT OWNER

Correspondence regarding provisionally recognized PTAB attorney filing

Dec 18, 2025EXHIBITBOARD

Corrected Notice of Intent to Designate Katherine A. Helm as Back-Up Counsel

Dec 18, 2025PAPERPATENT OWNER

Notice: Power of Attorney

Dec 16, 2025PAPERPATENT OWNER

Notice: Mandatory Notice

Dec 16, 2025PAPERPATENT OWNER

Declaration of Helm

Dec 16, 2025EXHIBITPATENT OWNER

Notice of Intent to Designate Katherine A. Helm as Back-Up Counsel

Dec 16, 2025PAPERPATENT OWNER

Notice: Notice filing date accorded

Dec 4, 2025PAPERBOARD

Ex. 1001

Nov 25, 2025EXHIBITPETITIONER

Ex. 1002

Nov 25, 2025EXHIBITPETITIONER

Ex. 1003

Nov 25, 2025EXHIBITPETITIONER

Ex. 1004

Nov 25, 2025EXHIBITPETITIONER

Ex. 1005

Nov 25, 2025EXHIBITPETITIONER

Ex. 1006

Nov 25, 2025EXHIBITPETITIONER

Ex. 1007

Nov 25, 2025EXHIBITPETITIONER

Ex. 1008

Nov 25, 2025EXHIBITPETITIONER

Ex. 1009

Nov 25, 2025EXHIBITPETITIONER

Ex. 1010

Nov 25, 2025EXHIBITPETITIONER

Ex. 1011

Nov 25, 2025EXHIBITPETITIONER

Ex. 1012

Nov 25, 2025EXHIBITPETITIONER

Ex. 1013

Nov 25, 2025EXHIBITPETITIONER

Ex. 1014

Nov 25, 2025EXHIBITPETITIONER

Ex. 1015

Nov 25, 2025EXHIBITPETITIONER

Ex. 1016

Nov 25, 2025EXHIBITPETITIONER

Ex. 1017

Nov 25, 2025EXHIBITPETITIONER

Ex. 1018

Nov 25, 2025EXHIBITPETITIONER

Ex. 1019

Nov 25, 2025EXHIBITPETITIONER

Ex. 1020

Nov 25, 2025EXHIBITPETITIONER

Ex. 1021

Nov 25, 2025EXHIBITPETITIONER

Ex. 1022

Nov 25, 2025EXHIBITPETITIONER

Ex. 1023

Nov 25, 2025EXHIBITPETITIONER

Ex. 1024

Nov 25, 2025EXHIBITPETITIONER

Ex. 1025

Nov 25, 2025EXHIBITPETITIONER

Ex. 1026

Nov 25, 2025EXHIBITPETITIONER

Ex. 1027

Nov 25, 2025EXHIBITPETITIONER

Ex. 1028

Nov 25, 2025EXHIBITPETITIONER

Ex. 1029

Nov 25, 2025EXHIBITPETITIONER

Ex. 1030

Nov 25, 2025EXHIBITPETITIONER

Ex. 1031

Nov 25, 2025EXHIBITPETITIONER

Ex. 1032

Nov 25, 2025EXHIBITPETITIONER

Ex. 1033

Nov 25, 2025EXHIBITPETITIONER

Ex. 1034

Nov 25, 2025EXHIBITPETITIONER

Ex. 1035

Nov 25, 2025EXHIBITPETITIONER

Ex. 1036

Nov 25, 2025EXHIBITPETITIONER

Ex. 1037

Nov 25, 2025EXHIBITPETITIONER

Ex. 1038

Nov 25, 2025EXHIBITPETITIONER

Ex. 1039

Nov 25, 2025EXHIBITPETITIONER

Ex. 1040

Nov 25, 2025EXHIBITPETITIONER

Ex. 1041

Nov 25, 2025EXHIBITPETITIONER

Notice: Power of Attorney

Nov 25, 2025PAPERPETITIONER

Petition: as filed

Nov 25, 2025PAPERPETITIONER